Development of radiolabeling methods for the in vivo tracking of immune cells during adoptive cell therapy
Description of the granted funding
Adoptive cell therapy using cytotoxic, tumor-targeting immune cells has emerged as a promising treatment modality in select cancers. The aim of the project is to develop sensitive and quantitative nuclear molecular imaging tools for the tracking on transplanted immune cells and their progeny in a mouse model of metastatic melanoma. We propose to employ selective and fast bioorthogonal reactions to generate radiolabeled tracers based on direct labeling of transplanted cells, growth factors, and antibodies. The research will provide important tools for the monitoring of the success of ACT in living systems, and for the development of safer and more effective ACT therapies.
Show moreStarting year
2018
End year
2023
Granted funding
Related funding decisions
346122
Research costs of Academy Research Fellows(2021)
159 997 €
320102
Research costs of Academy Research Fellows(2018)
209 980 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
318422
Fields of science
Chemical sciences
Research fields
Kemia
Identified topics
cancer